🦜 Novo Nordisk / @novonordisk
@nitter.poast.org.novonordisk@rss-parrot.net
I'm an automated parrot! I relay a website's RSS feed to the Fediverse. Every time a new post appears in the feed, I toot about it. Follow me to get all new posts in your Mastodon timeline!
Brought to you by the RSS Parrot.
---
Twitter feed for: @novonordisk. Generated by https://nitter.poast.org
Your feed and you don't want it here? Just
e-mail the birb.
Pinned: We are entering into a new strategic partnership with Amazon Web Services (@awscloud) to accelerate drug discovery through AI.
Learn more in the press release here: https://www.novonordisk.com/news-and-media/news-and-ir-materials/news-details.html?id=916594
https://nitter.poast.org/novonordisk/status/2086786290293375136#m
Published: August 10, 2026 12:06
We are entering into a new strategic partnership with Amazon Web Services (@awscloud) to accelerate drug discovery through AI.
Learn more in the press release here: novonordisk.com/news-and-med…
#PRESS Novo Nordisk wins Dutch court injunction protecting patients from unapproved, unlawful compounded semaglutide nasal spray.
Read more in the press release here: https://www.novonordisk.com/content/nncorp/global/en/news-and-media/news-and-ir-materials/news-details.html?id=916592
https://nitter.poast.org/novonordisk/status/2084999538247434465#m
Published: August 5, 2026 13:46
#PRESS Novo Nordisk wins Dutch court injunction protecting patients from unapproved, unlawful compounded semaglutide nasal spray.
Read more in the press release here: novonordisk.com/content/nnco…
Pinned: Our quarterly results are out.
Hear our CEO Mike Doustdar reflect on our results from the second quarter of 2026.
https://nitter.poast.org/novonordisk/status/2084684333546148277#m
Published: August 4, 2026 16:54
Our quarterly results are out.
Hear our CEO Mike Doustdar reflect on our results from the second quarter of 2026.
Video
#PRESS: Novo Nordisk raises adjusted sales and adjusted operating profit outlook for 2026.
Read more here: https://www.novonordisk.com/content/nncorp/global/en/news-and-media/news-and-ir-materials/news-details.html?id=916589
https://nitter.poast.org/novonordisk/status/2084681912811970687#m
Published: August 4, 2026 16:44
#PRESS: Novo Nordisk raises adjusted sales and adjusted operating profit outlook for 2026.
Read more here: novonordisk.com/content/nnco…
#PRESS We are announcing top-line results from a phase 3 cardiovascular outcomes trial.
Learn more in the company announcement here: https://www.novonordisk.com/content/nncorp/global/en/news-and-media/news-and-ir-materials/news-details.html?id=916587
https://nitter.poast.org/novonordisk/status/2083152792575676617#m
Published: July 31, 2026 11:28
#PRESS We are announcing top-line results from a phase 3 cardiovascular outcomes trial.
Learn more in the company announcement here: novonordisk.com/content/nnco…
Pinned: #PRESS Our GLP-1 pill for the treatment of obesity and injectable semaglutide 7.2 mg is approved in the EUÂ as we expand global access to obesity care. Read more here: https://www.novonordisk.com/
https://nitter.poast.org/novonordisk/status/2077427131135525277#m
Published: July 15, 2026 16:16
#PRESS Our GLP-1 pill for the treatment of obesity and injectable semaglutide 7.2 mg is approved in the EUÂ as we expand global access to obesity care. Read more here: novonordisk.com/
Pinned: #PRESS Novo Nordisk’s haemophilia A product demonstrated positive results in long-term safety and efficacy in the phase 3 FRONTIER extension study as presented at ISTH 2026. Read more here: https://www.novonordisk.com
https://nitter.poast.org/novonordisk/status/2075914123162919094#m
Published: July 11, 2026 12:04
#PRESS Novo Nordisk’s haemophilia A product demonstrated positive results in long-term safety and efficacy in the phase 3 FRONTIER extension study as presented at ISTH 2026. Read more here: novonordisk.com
#PRESS: We’re showcasing new data across our haemophilia portfolio at the ISTH Congress 2026.
Learn more in the press release here: https://www.novonordisk.com/news-and-media/news-and-ir-materials/news-details.html?id=916574
https://nitter.poast.org/novonordisk/status/2070494404243059019#m
Published: June 26, 2026 13:08
#PRESS: We’re showcasing new data across our haemophilia portfolio at the ISTH Congress 2026.
Learn more in the press release here: novonordisk.com/news-and-med…